Papers
9
Total Citations
96
H-Index
3
About
Tielong Tang is an emerging researcher specializing in robotic and minimally invasive urological surgery, with a particular focus on comparative surgical outcomes and the systematic evaluation of advanced surgical technologies. His work centers on robot-assisted procedures across a broad spectrum of urologic conditions, including prostate cancer, bladder cancer, renal tumors, and kidney transplantation. Tang's most impactful contribution to date is his 2023 systematic review and meta-analysis comparing robot-assisted versus open radical prostatectomy, which has garnered 70 citations and established him as a credible voice in the evolving debate over surgical approaches to prostate cancer. His subsequent research has tackled timely questions in the field, including the comparative performance of next-generation robotic platforms such as the Hinotori surgical system against the gold-standard da Vinci system, and the clinical utility of innovations like the AirSeal insufflation system and intraoperative indocyanine green imaging. By consistently applying rigorous meta-analytic methodology, Tang helps clinicians and policymakers navigate complex decisions surrounding surgical technology adoption. His rapidly expanding portfolio, with multiple publications in 2025 alone, signals a productive and prolific research trajectory that will likely grow in influence as robotic surgery continues to transform urological care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9